JG
BCRX icon

Jain Global’s BioCryst Pharmaceuticals BCRX Stock Holding History

Jain Global’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$830K Buy
+82,952
New +$750K ﹤0.01% 1039
2026
Q1 		– Sell
-74,455
Closed -$581K – 1223
2025
Q4 		$581K Buy
+74,455
New +$538K ﹤0.01% 801
2025
Q3 		– Sell
-240,693
Closed -$2.16M – 1042
2025
Q2 		$2.16M Buy
+240,693
New +$2.24M 0.02% 489
2025
Q1 		– Sell
-86,300
Closed -$649K – 1077
2024
Q4 		$649K Buy
+86,300
New +$655K 0.02% 397

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Jain Global's BCRX Position: Q2 2026 in Review

Jain Global opened a new position in BioCryst Pharmaceuticals (BCRX) in Q2 2026: 82,952 shares worth $830K. The stake represents ﹤0.01% of the portfolio and ranks #1039 among its holdings. This is a return to the name: Jain Global previously reported a position in BCRX as recently as Q4 2025.

Jain Global first reported a position in BCRX in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.16M in Q2 2025. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Jain Global held 82,952 shares of BioCryst Pharmaceuticals worth $830K as of Q2 2026.
  • BioCryst Pharmaceuticals was a new Jain Global position in Q2 2026.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1039 holding.
  • Jain Global first reported a position in BioCryst Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Jain Global's BioCryst Pharmaceuticals position peaked at $2.16M in Q2 2025.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.